CVS Health Corporation with ticker code (CVS) have now 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The target price High/Low ranges between 143 and 87 and has a mean target at $110.90. Given that the stocks previous close was at $77.54 and the analysts are correct then there would likely be a percentage uptick in value of 43.0%. It’s also worth noting that there is a 50 day moving average of $81.32 while the 200 day moving average is $92.79. The company has a market capitalization of $97,644m. Company Website: https://www.cvshealth.com
The potential market cap would be $139,653m based on the market consensus.
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
The company has a dividend yield of 3.12% with the ex dividend date set at 20-4-2023 (DMY).
Other points of data to note are a P/E ratio of 24.22, revenue per share of 245.14 and a 4.18% return on assets.
